CysBio (private company)

cysbio.com Follow

See something wrong or missing? Let us know

Offices:

Copenhagen

Category:

Biotech Health services

Business model:

B2B

Investors:

we tracked 1 investor

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Cysbio uses advanced metabolic engineering and synthetic biology approaches to construct bacterial cell factories for transforming the production of biochemicals from renewable feedstocks.

Cysbio is a spin-out from the Novo Nordisk Foundation Center for Biosustainability at the Technical University of Denmark.

Companies with similar profile to CysBio:

Company	Criteria
Gradientech 44%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 5M - 10M USD
Scandinavian Real Hearts 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Oncoinvent 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Optomed 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Aprea Therapeutics 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
NMD Pharma 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
TILT Biotherapeutics 44%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 5M - 10M USD
ITBMed 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Galecto Biotech 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Alvotech 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Mobidiag 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Chundsell Medicals 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Aiforia 43%	Similar verticals: Health services Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
Sorbwater Technology 43%	Similar verticals: Biotech Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
Naava 43%	Similar verticals: Health services Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
Valkee 43%	Similar verticals: Health services Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
AMRA 43%	Similar verticals: Health services Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
BC Platforms 43%	Similar verticals: Health services Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
Biosyntia 43%	Similar verticals: Biotech Similar business models: B2B Total raised in a similar range: 5M - 10M USD Minim one investor from outside Scandinavia: Yes
Quretech Bio 34%	Similar verticals: Biotech, Health services Similar business models: B2B